Search by Drug Name or NDC
NDC 72000-0030-06 Citric Buffered Normal Saline 166 mg/270mL Details
Citric Buffered Normal Saline 166 mg/270mL
Citric Buffered Normal Saline is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nabriva Therapeutics US, Inc.. The primary component is ANHYDROUS CITRIC ACID.
Product Information
| NDC | 72000-0030 |
|---|---|
| Product ID | 72000-030_772b4b36-4627-4087-8a16-c1ed771939c4 |
| Associated GPIs | 98401040402020 |
| GCN Sequence Number | 080239 |
| GCN Sequence Number Description | diluent for lefamulin PLAST. BAG INTRAVEN |
| HIC3 | C5O |
| HIC3 Description | DILUENT SOLUTIONS |
| GCN | 46979 |
| HICL Sequence Number | 046032 |
| HICL Sequence Number Description | DILUENT FOR LEFAMULIN(10MM CITRATE BUFFERED 0.9 % SOD CHLOR) |
| Brand/Generic | Brand |
| Proprietary Name | Citric Buffered Normal Saline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | anhydrous citric acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 166 |
| Active Ingredient Units | mg/270mL |
| Substance Name | ANHYDROUS CITRIC ACID |
| Labeler Name | Nabriva Therapeutics US, Inc. |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA211673 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72000-0030-06 (72000003006)
| NDC Package Code | 72000-030-06 |
|---|---|
| Billing NDC | 72000003006 |
| Package | 6 BAG in 1 CARTON (72000-030-06) / 270 mL in 1 BAG (72000-030-01) |
| Marketing Start Date | 2019-09-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |